Loading…

Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection

Cytomegalovirus is a promising vaccine vector; however, mechanisms promoting CD4 T cell responses to challenge, by CMV as a vector, are unknown. The ability of MCMV to prolong immunity generated by short-lived malaria vaccine was tested. MCMV provided non-specific protection to challenge with Plasmo...

Full description

Saved in:
Bibliographic Details
Published in:iScience 2024-12, Vol.27 (12), p.111468, Article 111468
Main Authors: Gbedande, Komi, Ibitokou, Samad A., Endrino, Mark Joseph D., Yap, George S., Brown, Michael G., Stephens, Robin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c347t-baefd4db38a1c9cdb9d3903295741099c485d051160dc730dfd13b33a88781703
container_end_page
container_issue 12
container_start_page 111468
container_title iScience
container_volume 27
creator Gbedande, Komi
Ibitokou, Samad A.
Endrino, Mark Joseph D.
Yap, George S.
Brown, Michael G.
Stephens, Robin
description Cytomegalovirus is a promising vaccine vector; however, mechanisms promoting CD4 T cell responses to challenge, by CMV as a vector, are unknown. The ability of MCMV to prolong immunity generated by short-lived malaria vaccine was tested. MCMV provided non-specific protection to challenge with Plasmodium and increased interleukin-12 (IL-12) and CD8α+ dendritic cell (DC) numbers through prolonged MCMV-dependent interferon gamma (IFN-γ) production. This late innate response to MCMV increased IL-12 upon challenge and increased the polyclonal CD4 effector T cell response to Plasmodium, protecting in an IL-12-dependent manner. Although Plasmodium-vaccine-induced protection decayed by d200, MCMV restored protection through IFN-γ. Mechanistically, protection depended on MCMV-induced-IFN-γ increasing CD8α+ DCs and IL-12p40. MCMV expressing a Plasmodium epitope increased parasite-specific CD4 effector and effector memory T cells persisting after malaria vaccination, both phenotypes reported to protect. Overall, enhanced innate cell status, a mechanism of heterologous protection by MCMV, led to a stronger T cell response to challenge. [Display omitted] •MCMV-B5 vector maintains specific CD4 T cells and effector memory phenotype•IFN-γ from persistent MCMV increases CD8α+ DCs, IL-12, and effector T cell response•Neutralization of IL-12 during challenge limits MCMV-based protection•MCMV-induced innate immune state improves T cell response to Plasmodium challenge Natural sciences; Biological sciences; Immunology; Immune response; Microbiology; Viral microbiology
doi_str_mv 10.1016/j.isci.2024.111468
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_bf136090a4f9463abd7179b214406067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2589004224026956</els_id><doaj_id>oai_doaj_org_article_bf136090a4f9463abd7179b214406067</doaj_id><sourcerecordid>3151879622</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-baefd4db38a1c9cdb9d3903295741099c485d051160dc730dfd13b33a88781703</originalsourceid><addsrcrecordid>eNp9kc9q3DAQxk1paUKaF-ih6NjLbvXPlgW9lNA2gUAv7VmMpfGuFlnaSt6FvECfO3Kchp4KAkkz33zDzK9p3jO6ZZR1nw5bX6zfcsrlljEmu_5Vc8nbXm8olfz1P--L5rqUA6WU1yN197a5EFrVrBaXzZ9b9Lv9jBEd8THCjMRP0ykiKfPTJ7qTrbnhgZx9hkDOaOeUSUBwhcyJYNxDXBQZyzHFgkvQ7iEEjDskEB055hRS3BUyQYDsgZzBWl9b1MRc7XyK75o3I4SC18_3VfPr29efN7eb-x_f726-3G-skGreDICjk24QPTCrrRu0E5oKrlslGdXayr51tGWso84qQd3omBiEgL5XPVNUXDV3q69LcDDH7CfIDyaBN0-BlHcG8uxtQDOMTHRUU5Cjlp2AwSmm9MCZlLSjnapeH1evOsbvE5bZTBUJhgAR06kYwVrWK91xXqV8ldqcSsk4vrRm1Cw4zcEsOM2C06w4a9GHZ__TMKF7KfkLrwo-rwKsGzt7zKZa4ALD57rWOpL_n_8j2Xexcg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3151879622</pqid></control><display><type>article</type><title>Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection</title><source>ScienceDirect Journals</source><source>PubMed Central</source><creator>Gbedande, Komi ; Ibitokou, Samad A. ; Endrino, Mark Joseph D. ; Yap, George S. ; Brown, Michael G. ; Stephens, Robin</creator><creatorcontrib>Gbedande, Komi ; Ibitokou, Samad A. ; Endrino, Mark Joseph D. ; Yap, George S. ; Brown, Michael G. ; Stephens, Robin</creatorcontrib><description>Cytomegalovirus is a promising vaccine vector; however, mechanisms promoting CD4 T cell responses to challenge, by CMV as a vector, are unknown. The ability of MCMV to prolong immunity generated by short-lived malaria vaccine was tested. MCMV provided non-specific protection to challenge with Plasmodium and increased interleukin-12 (IL-12) and CD8α+ dendritic cell (DC) numbers through prolonged MCMV-dependent interferon gamma (IFN-γ) production. This late innate response to MCMV increased IL-12 upon challenge and increased the polyclonal CD4 effector T cell response to Plasmodium, protecting in an IL-12-dependent manner. Although Plasmodium-vaccine-induced protection decayed by d200, MCMV restored protection through IFN-γ. Mechanistically, protection depended on MCMV-induced-IFN-γ increasing CD8α+ DCs and IL-12p40. MCMV expressing a Plasmodium epitope increased parasite-specific CD4 effector and effector memory T cells persisting after malaria vaccination, both phenotypes reported to protect. Overall, enhanced innate cell status, a mechanism of heterologous protection by MCMV, led to a stronger T cell response to challenge. [Display omitted] •MCMV-B5 vector maintains specific CD4 T cells and effector memory phenotype•IFN-γ from persistent MCMV increases CD8α+ DCs, IL-12, and effector T cell response•Neutralization of IL-12 during challenge limits MCMV-based protection•MCMV-induced innate immune state improves T cell response to Plasmodium challenge Natural sciences; Biological sciences; Immunology; Immune response; Microbiology; Viral microbiology</description><identifier>ISSN: 2589-0042</identifier><identifier>EISSN: 2589-0042</identifier><identifier>DOI: 10.1016/j.isci.2024.111468</identifier><identifier>PMID: 39758993</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Biological sciences ; Immune response ; Immunology ; Microbiology ; Natural sciences ; Viral microbiology</subject><ispartof>iScience, 2024-12, Vol.27 (12), p.111468, Article 111468</ispartof><rights>2024 The Authors</rights><rights>2024 The Authors.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c347t-baefd4db38a1c9cdb9d3903295741099c485d051160dc730dfd13b33a88781703</cites><orcidid>0000-0002-3229-5566 ; 0000-0001-8036-600X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2589004224026956$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3535,27903,27904,45759</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39758993$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gbedande, Komi</creatorcontrib><creatorcontrib>Ibitokou, Samad A.</creatorcontrib><creatorcontrib>Endrino, Mark Joseph D.</creatorcontrib><creatorcontrib>Yap, George S.</creatorcontrib><creatorcontrib>Brown, Michael G.</creatorcontrib><creatorcontrib>Stephens, Robin</creatorcontrib><title>Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection</title><title>iScience</title><addtitle>iScience</addtitle><description>Cytomegalovirus is a promising vaccine vector; however, mechanisms promoting CD4 T cell responses to challenge, by CMV as a vector, are unknown. The ability of MCMV to prolong immunity generated by short-lived malaria vaccine was tested. MCMV provided non-specific protection to challenge with Plasmodium and increased interleukin-12 (IL-12) and CD8α+ dendritic cell (DC) numbers through prolonged MCMV-dependent interferon gamma (IFN-γ) production. This late innate response to MCMV increased IL-12 upon challenge and increased the polyclonal CD4 effector T cell response to Plasmodium, protecting in an IL-12-dependent manner. Although Plasmodium-vaccine-induced protection decayed by d200, MCMV restored protection through IFN-γ. Mechanistically, protection depended on MCMV-induced-IFN-γ increasing CD8α+ DCs and IL-12p40. MCMV expressing a Plasmodium epitope increased parasite-specific CD4 effector and effector memory T cells persisting after malaria vaccination, both phenotypes reported to protect. Overall, enhanced innate cell status, a mechanism of heterologous protection by MCMV, led to a stronger T cell response to challenge. [Display omitted] •MCMV-B5 vector maintains specific CD4 T cells and effector memory phenotype•IFN-γ from persistent MCMV increases CD8α+ DCs, IL-12, and effector T cell response•Neutralization of IL-12 during challenge limits MCMV-based protection•MCMV-induced innate immune state improves T cell response to Plasmodium challenge Natural sciences; Biological sciences; Immunology; Immune response; Microbiology; Viral microbiology</description><subject>Biological sciences</subject><subject>Immune response</subject><subject>Immunology</subject><subject>Microbiology</subject><subject>Natural sciences</subject><subject>Viral microbiology</subject><issn>2589-0042</issn><issn>2589-0042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kc9q3DAQxk1paUKaF-ih6NjLbvXPlgW9lNA2gUAv7VmMpfGuFlnaSt6FvECfO3Kchp4KAkkz33zDzK9p3jO6ZZR1nw5bX6zfcsrlljEmu_5Vc8nbXm8olfz1P--L5rqUA6WU1yN197a5EFrVrBaXzZ9b9Lv9jBEd8THCjMRP0ykiKfPTJ7qTrbnhgZx9hkDOaOeUSUBwhcyJYNxDXBQZyzHFgkvQ7iEEjDskEB055hRS3BUyQYDsgZzBWl9b1MRc7XyK75o3I4SC18_3VfPr29efN7eb-x_f726-3G-skGreDICjk24QPTCrrRu0E5oKrlslGdXayr51tGWso84qQd3omBiEgL5XPVNUXDV3q69LcDDH7CfIDyaBN0-BlHcG8uxtQDOMTHRUU5Cjlp2AwSmm9MCZlLSjnapeH1evOsbvE5bZTBUJhgAR06kYwVrWK91xXqV8ldqcSsk4vrRm1Cw4zcEsOM2C06w4a9GHZ__TMKF7KfkLrwo-rwKsGzt7zKZa4ALD57rWOpL_n_8j2Xexcg</recordid><startdate>20241220</startdate><enddate>20241220</enddate><creator>Gbedande, Komi</creator><creator>Ibitokou, Samad A.</creator><creator>Endrino, Mark Joseph D.</creator><creator>Yap, George S.</creator><creator>Brown, Michael G.</creator><creator>Stephens, Robin</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-3229-5566</orcidid><orcidid>https://orcid.org/0000-0001-8036-600X</orcidid></search><sort><creationdate>20241220</creationdate><title>Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection</title><author>Gbedande, Komi ; Ibitokou, Samad A. ; Endrino, Mark Joseph D. ; Yap, George S. ; Brown, Michael G. ; Stephens, Robin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-baefd4db38a1c9cdb9d3903295741099c485d051160dc730dfd13b33a88781703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biological sciences</topic><topic>Immune response</topic><topic>Immunology</topic><topic>Microbiology</topic><topic>Natural sciences</topic><topic>Viral microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gbedande, Komi</creatorcontrib><creatorcontrib>Ibitokou, Samad A.</creatorcontrib><creatorcontrib>Endrino, Mark Joseph D.</creatorcontrib><creatorcontrib>Yap, George S.</creatorcontrib><creatorcontrib>Brown, Michael G.</creatorcontrib><creatorcontrib>Stephens, Robin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>iScience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gbedande, Komi</au><au>Ibitokou, Samad A.</au><au>Endrino, Mark Joseph D.</au><au>Yap, George S.</au><au>Brown, Michael G.</au><au>Stephens, Robin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection</atitle><jtitle>iScience</jtitle><addtitle>iScience</addtitle><date>2024-12-20</date><risdate>2024</risdate><volume>27</volume><issue>12</issue><spage>111468</spage><pages>111468-</pages><artnum>111468</artnum><issn>2589-0042</issn><eissn>2589-0042</eissn><abstract>Cytomegalovirus is a promising vaccine vector; however, mechanisms promoting CD4 T cell responses to challenge, by CMV as a vector, are unknown. The ability of MCMV to prolong immunity generated by short-lived malaria vaccine was tested. MCMV provided non-specific protection to challenge with Plasmodium and increased interleukin-12 (IL-12) and CD8α+ dendritic cell (DC) numbers through prolonged MCMV-dependent interferon gamma (IFN-γ) production. This late innate response to MCMV increased IL-12 upon challenge and increased the polyclonal CD4 effector T cell response to Plasmodium, protecting in an IL-12-dependent manner. Although Plasmodium-vaccine-induced protection decayed by d200, MCMV restored protection through IFN-γ. Mechanistically, protection depended on MCMV-induced-IFN-γ increasing CD8α+ DCs and IL-12p40. MCMV expressing a Plasmodium epitope increased parasite-specific CD4 effector and effector memory T cells persisting after malaria vaccination, both phenotypes reported to protect. Overall, enhanced innate cell status, a mechanism of heterologous protection by MCMV, led to a stronger T cell response to challenge. [Display omitted] •MCMV-B5 vector maintains specific CD4 T cells and effector memory phenotype•IFN-γ from persistent MCMV increases CD8α+ DCs, IL-12, and effector T cell response•Neutralization of IL-12 during challenge limits MCMV-based protection•MCMV-induced innate immune state improves T cell response to Plasmodium challenge Natural sciences; Biological sciences; Immunology; Immune response; Microbiology; Viral microbiology</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39758993</pmid><doi>10.1016/j.isci.2024.111468</doi><orcidid>https://orcid.org/0000-0002-3229-5566</orcidid><orcidid>https://orcid.org/0000-0001-8036-600X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2589-0042
ispartof iScience, 2024-12, Vol.27 (12), p.111468, Article 111468
issn 2589-0042
2589-0042
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_bf136090a4f9463abd7179b214406067
source ScienceDirect Journals; PubMed Central
subjects Biological sciences
Immune response
Immunology
Microbiology
Natural sciences
Viral microbiology
title Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T17%3A45%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heightened%20innate%20immune%20state%20induced%20by%20viral%20vector%20leads%20to%20enhanced%20response%20to%20challenge%20and%20prolongs%20malaria%20vaccine%20protection&rft.jtitle=iScience&rft.au=Gbedande,%20Komi&rft.date=2024-12-20&rft.volume=27&rft.issue=12&rft.spage=111468&rft.pages=111468-&rft.artnum=111468&rft.issn=2589-0042&rft.eissn=2589-0042&rft_id=info:doi/10.1016/j.isci.2024.111468&rft_dat=%3Cproquest_doaj_%3E3151879622%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c347t-baefd4db38a1c9cdb9d3903295741099c485d051160dc730dfd13b33a88781703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3151879622&rft_id=info:pmid/39758993&rfr_iscdi=true